Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Mission Pharmacal Company has joined TriLogic Pharma to make use of its technology in developing a new drug delivery system.
Subscribe to our email newsletter
The delivery system will be based upon TriLogic drug delivery platform TRI-726 and will be licensed to Mission Pharmacal for future drug development with focus on women’s health medication.
TRI-726 can deliver many actives over several hours to several days and focuses on in-situ gelation, sustained-erosion and bio-resorption, and adhesion.
Mission Pharmacal Commercial Operations president Terry Herring said the company looks forward to working with TriLogic and its new technology.